INTRODUCTION
============

The incidence of chronic diseases, such as metabolic syndrome, hypertension, dyslipidemia, diabetes, and obesity, is increasing worldwide and is attributed to long-term exposure to an unhealthy lifestyle. As a prophylactic agent against disease, supplementation food with probiotics has various benefits on human health. Clinical studies have shown the effectiveness of probiotics for immunomodulation, reducing serum cholesterol, and preventing diseases such as obesity, insulin resistance syndrome, type 2 diabetes, gastrointestinal diseases, allergic diseases, and colon cancer ([@b38-pnfs-24-434]; [@b52-pnfs-24-434]).

Among the probiotics, *Lactobacillus plantarum* (*Lab. plantarum*) is supplemented in food, and shows beneficial effect on the intestinal balance and health of the host. *Lab. plantarum* can be isolated from human breast milk ([@b25-pnfs-24-434]), human feces ([@b2-pnfs-24-434]; [@b8-pnfs-24-434]), dairy products ([@b21-pnfs-24-434]; [@b41-pnfs-24-434]), and Asian fermented fruits and vegetables ([@b3-pnfs-24-434]; [@b7-pnfs-24-434]; [@b11-pnfs-24-434]; [@b34-pnfs-24-434]; [@b48-pnfs-24-434]; [@b55-pnfs-24-434]; [@b57-pnfs-24-434]). Interestingly, the function and efficacy of probiotics depend on the strain, and may vary by the isolation sources. Kimchi is a popular and widely consumed Korean traditional fermented vegetable, which has been evaluated as one of the healthiest food in the world. Kimchi contains various bioactive components, including dietary fiber, vitamin C, and β-carotene. The intake of kimchi, which contains lactic acid bacteria, may have protective benefits on human organs, such as the gut, heart, and brain ([@b36-pnfs-24-434]).

*Lab. plantarum* is one of the important lactic acid bacteria identified during the fermentation of kimchi ([@b27-pnfs-24-434]; [@b48-pnfs-24-434]; [@b55-pnfs-24-434]). As intestinal microbes, some *Lab. plantarum* strains have potential bile salt hydrolase (BSH) activity ([@b5-pnfs-24-434]; [@b29-pnfs-24-434]; [@b31-pnfs-24-434]; [@b51-pnfs-24-434]). Strains of probiotics with BSH activity are considered capable of reducing serum cholesterol levels ([@b29-pnfs-24-434]; [@b39-pnfs-24-434]; [@b59-pnfs-24-434]). The main mechanism by which probiotics lower cholesterol is thought to lie in the biotransformation reaction of bile salt deconjugation, which is functional in bile detoxification ([@b20-pnfs-24-434]; [@b39-pnfs-24-434]; [@b49-pnfs-24-434]). Isolation and identification of probiotics that are present in natural foods can be an alternative method of prevention and a treatment strategy for hypercholesterolemia.

Another definable benefit of *Lab. plantarum* is its efficacy for regulating obesity. Obesity increases circulating cholesterol and triglyceride levels, and causes metabolic syndrome ([@b17-pnfs-24-434]). Peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT-enhancer-binding protein α (C/EBPα) regulate the early stage of adipocyte differentiation by activating adipogenic markers such as fatty acid synthase (FAS), cluster of differentiation 36 (CD36), leptin, glyceraldehyde-3-phosphate dehydrogenase (GPDH), and adipocyte fatty acid binding protein (aP2), which trigger accumulation of lipid in the cells. *Lab. plantarum* has been reported to inhibit the differentiation and lipid accumulation in adipocytes by downregulating expression of PPARγ, C/EBPα, FAS, aP2, leptin, GPDH, and CD36 ([@b19-pnfs-24-434]; [@b43-pnfs-24-434]; [@b46-pnfs-24-434]). Administration of *Lab. plantarum* to diet-induced obese mice induced reductions in adipocyte size and white adipose tissue weight, and anti-obesity effects including decreases in serum total cholesterol and leptin concentrations ([@b32-pnfs-24-434]; [@b42-pnfs-24-434]; [@b45-pnfs-24-434]; [@b56-pnfs-24-434]).

*Lab. plantarum* has the generally recognized as safe (GRAS) status from the European Union and qualified presumption of safety (QPS) status from the U.S. Food and Drug Administration ([@b53-pnfs-24-434]). This study aimed to isolate a *Lab. plantarum* strain from naturally fermented kimchi that can be used as a dietary supplement for healthcare. We isolated the *Lab. plantarum* strain TCI378, and confirmed the potential abilities of TCI378 and its metabolites on gastrointestinal functions, fat metabolism and anti-obesity effects by *in vitro* examination.

MATERIALS AND METHODS
=====================

Isolation and preliminary identification of *Lab. plantarum*
------------------------------------------------------------

Homogenates of naturally fermented kimchi were mixed with de Man Rogosa Sharpe (MRS) broth (Difco Laboratories Inc., Detroit, MI, USA) at a ratio (v/v) of 1:100. The mixture was cultured in anaerobic conditions (with an oxygen concentration \<1%, AnaeroPack^®^ System, Mitsubishi Gas Chemical Company, Inc., Tokyo, Japan) at 37°C for 18 h. The overnight culture was streaked on a solid MRS agar plate and cultured overnight in anaerobic conditions at 37°C for single colony growth. Isolates were Gram-stained and characterized by carbohydrate utilization patterns using an API 50 CH system (bioMérieux, Inc., Durham, NC, USA). All isolates were subcultured three times prior to experimental analysis.

Candidate isolates were identified by phylogenetic analysis of the 16S rDNA sequence. Chromosomal DNA from each strain was extracted and 16S rRNA was amplified using universal primers. Polymerase chain reaction (PCR) primer sequences were as follows: forward primer, 5′-AGA GTT TGA TCC TGG CTC AG-3′; reverse primer, 5′-GGT TAC CTT TGT TAC GAC TT-3′ (Tri-I Biotech, Inc., Taipei, Taiwan). The thermal cycling parameters were: denaturation at 95°C for 5 min, followed by 30 cycles of denaturation at 95°C for 1 min, annealing at 55°C for 1 min, polymerization at 72°C for 40 s, and final polymerization at 72°C for 5 min. Amplified products were purified using a Gel Extraction Kit (GeneMark, Taichung, Taiwan), and sequenced. Sequence homologies of 16S rDNA were examined by blasting the online DNA database of National Center for Biotechnology Information (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>).

Low pH and bile salts tolerance test
------------------------------------

The ability of bacteria to grow at low pH was evaluated as described previously ([@b10-pnfs-24-434]). Bacteria were grown in MRS broth at 37°C overnight, then subcultured in fresh MRS broth and incubated for a further 24 h. Cultures were pelleted, washed twice and resuspended in sterile phosphate-buffered saline (PBS). Bacteria were diluted 1/100 in PBS at pH 3.0 and incubated at 37°C for 3 h. Bacteria incubated in PBS at pH 7.0 were used as controls. Bacterial cultures (100 μL) was transferred to MRS agar and broth, and incubated anaerobically at 37°C for 48 h. Counts of surviving cells were determined on MRS agar plates.

The tolerance of bacteria to bile salts was determined as described previously ([@b14-pnfs-24-434]) with modifications. The bacteria were grown overnight in MRS broth. Freshly-prepared overnight cultures (2%) were inoculated in tubes containing MRS broth with 0.3% oxgall bile acids (Difco Laboratories Inc.); MRS broth without bile acids was used as the control. Tolerance to bile acid was evaluated by measuring cell viability after 3 h incubation at 42°C. Bacterial cultures (100 μL) were plated in duplicate onto MRS agar plates and bacterial numbers were counted after 48 h incubation.

BSH activity assay
------------------

The bile salt hydrolase activity was determined as previously described ([@b9-pnfs-24-434]). *Lab. plantarum* strains were cultured on MRS agar plates containing 0.5% taurodeoxycholic acid sodium (TDCA, Sigma, St. Louis, MO, USA). After incubation at 37°C for 2 days, colonies surrounded by a halo of precipitated-free bile acids and those forming opaque granular white colonies were regarded as having high BSH activity. The bile salt emulsification process was created as described ([@b13-pnfs-24-434]) with modifications. The cell-free supernatant of *Lab. plantarum* cultured in MRS broth containing 0.3% bile acids was collected and filtered to purify metabolites. Soy oil (1 mL) was mixed with 4 mL MRS broth containing bile salts or purified metabolites of bacterial culture, and the emulsification effect was observed.

Cholesterol-lowering test
-------------------------

Cholesterol-lowering activity was determined by using the cholesterol quantitation kit (\#MAK043, Sigma) and by reference to a previously described method ([@b64-pnfs-24-434]). Bacteria were cultured at 37°C in MRS broth supplemented with 0.2% oxgall bile acids (Difco Laboratories Inc.) and 0.1 g water soluble cholesterol. Following incubation, bacterial cells were harvested by centrifugation (10,000 rpm, 5 min). The supernatant and un-inoculated control MRS broth were assayed to determine the content of cholesterol through measuring absorbance at 570 nm using a spectrophotometer. The ability of each culture to lower cholesterol was calculated through the reduction of cholesterol concentration in broth supernatant at the end of the experiment.

Adipocyte culture and sample treatment
--------------------------------------

3T3-L1 cells were derived from the American Type Culture Collection (CL-173, Manassas, VA, USA). Culture of 3T3-L1 cells and adipogenesis induction were performed as previously described ([@b33-pnfs-24-434]) with modifications. Cells were cultured in pre-adipocyte expansion medium based on Dulbecco's modified Eagle's medium (DMEM, Gibco, Grand Island, NY, USA) supplemented with 10% bovine serum (Gibco) and 1% penicillin/streptomycin (Gibco). Cells were seeded at a density of 8×10^4^ cells/well in 24-well culture plates in triplicate (n=3). Confluent cells were cultured in adipocyte differentiation cocktail medium \[0.5 mM methylisobutylxanthine (IBMX, Sigma), 1 μM dexamethasone (Sigma), and 1 μg/mL insulin (Sigma) in DMEM supplemented with 10% fetal bovine serum (FBS)\] for 4 days, then in adipocyte maintenance medium (DMEM supplemented with 10% FBS and 1 μg/mL insulin) for 2 days, followed by DMEM supplemented with 10% FBS for a further 8 days. Cells were then cultured in a CO~2~ incubator at 37°C for adipocyte differentiation to complete. Differentiated adipocytes were treated with 1% MRS as a blank, or 1% culture supernatant of TCI378 without cells, and cultured in a CO~2~ incubator at 37°C for 2 days.

Oil red O staining of adipocytes
--------------------------------

Intracellular lipid accumulation was measured using Oil red O staining. Oil red O staining of 3T3-L1 cells were performed as previously described ([@b33-pnfs-24-434]) with modifications. 3T3-L1 cells were fixed with 10% formaldehyde/PBS and stained with Oil red O (Sigma). To assess lipid accumulation, the dye was extracted from stained cells with isopropanol, and was measured spectrophotometrically at 510 nm ([@b15-pnfs-24-434]). The percentage of Oil red O stained material from treated wells relative to that from control wells was calculated.

Quantification of adipocyte-specific gene expressions by real-time PCR
----------------------------------------------------------------------

Treated adipocytes were harvested, and total RNA was isolated from cells using an RNA purification kit (Gene-Mark). DNA-free total RNA was reverse transcribed to cDNA using the SuperScript^TM^ Reverse Transcriptase kit (Invitrogen, Carlsbad, CA, USA). Quantitative real-time PCR was conducted using ABI StepOnePlus^TM^ Real-Time PCR System (Thermo Fisher Scientific, Inc., Waltham, MA, USA) and the SYBR Green Master Mix (KAPA Biosystems, Inc., Wilmington, MA, USA). Cycling conditions were as follows: one cycle at 95°C for 20 s, then 40 cycles of 95°C for 1 s, and 60°C for 20 s. The following primers were used for amplification: perilipin 1 (*PLIN1*, XM_011250776), forward (5′-GGG ACC TGT GAG TGC TTC C-3′) and reverse (5′-GTA TTG AAG AGC CGG GAT CTT TT-3′); glucose transporter type 4 (*GLUT4*, NM_001359114), forward (5′-GTG ACT GGA ACA CTG GTC CTA-3′) and reverse (5′-CCA GCC ACG TTG CAT TGT AG-3′). The β-actin gene (NM_007393) was used for normalization, amplified using the primers: forward (5′-GGC TGT ATT CCC CTC CAT CG-3′) and reverse (5′-CCA GTT GGT AAC AAT GCC ATG T-3′). Data were analyzed using the ABI StepOne^TM^ Software v2.2.3 (Thermo Fisher Scientific, Inc.). All PCR assays were performed in duplicate three times.

Statistical asnalysis
---------------------

All values are expressed as mean±standard deviation (SD). The statistical significance of the differences between two sample populations was determined by unpaired two-tailed Student's *t*-tests. Statistical significance was considered at *P*\<0.05.

RESULTS AND DISCUSSION
======================

*Lab. plantarum* TCI378 was isolated from naturally fermented kimchi
--------------------------------------------------------------------

A total of 32 bacterial colonies were isolated from naturally fermented kimchi, and were subjected to autosequencing for identity confirmation. Among these 32 colonies, 23 were identified as *Lab. plantarum*, 5 were identified as *Leuconostoc mesenteroides* and 4 were identified as *Lactobacillus coryniformis* by 16S rDNA sequence analysis. Strain of each species with the best growth rates were subjected to the Oil red O staining assay. Quantification results showed the *Lab. plantarum* strain reduced 15% of lipid droplets, the *Leu. mesenteroides* strain reduced 12%, and *Lab. coryniformis* strain reduced 9% (data not shown). In this study, we focused on the novel *Lab. plantarum* strain TCI378, which has 99% sequence identity homology at the 16S rRNA gene. *Lab. plantarum* TCI378 was deposited at the Food Industry Research and Development Institute (Hsinchu, Taiwan) under the accession number BCRC 910760 and at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen und Zellkulturen) under the accession number DSM 32451. Although many *Lab. plantarum* strains have been isolated from fermented foods, the probiotic characteristics of each are considered to be source-specific ([@b16-pnfs-24-434]; [@b50-pnfs-24-434]; [@b61-pnfs-24-434]; [@b62-pnfs-24-434]). *Lab. plantarum* strains isolated from kimchi have been reported to have beneficial functions in immunoregulation, cancer treatment, skin moisturizing, and anti-obesity ([@b18-pnfs-24-434]; [@b28-pnfs-24-434]; [@b30-pnfs-24-434]; [@b44-pnfs-24-434]). The identification of *Lab. plantarum* strain TCI378 from indigenous kimchi enabled us to investigate its probiotic properties.

*Lab. plantarum* TCI378 is resistant to low pH and bile salt
------------------------------------------------------------

In the low pH tolerance test, the cell count of TCI378 in MRS medium of pH 7.0 was 1.97×10^9^ colony-forming unit (CFU)/mL. In MRS medium of pH 3.0, the cell count of TCI378 was 1.76×10^9^ CFU/mL. The survival rate of TCI378 in pH 3.0 was calculated from the base 10 logarithm, and showed a cell viability of 99.5% compared with the cell number for those cultured at pH 7.0 ([Fig. 1A](#f1-pnfs-24-434){ref-type="fig"}). In the bile salt tolerance test, the cell count of TCI378 in MRS medium lacking bile acids was 1.2×10^10^ CFU/mL, whereas the cell count of TCI378 cultured in MRS medium supplemented with 0.3% bile acids was 4.3×10^9^ CFU/mL. The survival rate of TCI378 in 0.3% bile acids was 95.6% compared to the number of viable cells cultured in the control culture ([Fig. 1B](#f1-pnfs-24-434){ref-type="fig"}). These results show TCI378 is capable of survival at a low pH and in bile salts, indicating that TCI378 has potential as a probiotics to grow in gastrointestinal juice and function in the upper digestive tract ([@b40-pnfs-24-434]).

*Lab. plantarum* TCI378 possesses bile salt hydrolase and cholesterol-lowering activities
-----------------------------------------------------------------------------------------

In MRS medium containing TDCA, taurine-conjugated bile acid is deconjugated and deoxycholic acid is produced by bile salt hydrolase-producing Lactobacilli ([@b9-pnfs-24-434]). *Lab. plantarum* TCI378 grown on MRS agar plates containing 0.5% TDCA formed opaque granular white colonies ([Fig. 2A](#f2-pnfs-24-434){ref-type="fig"}). Therefore, TCI378 was regarded as having bile salt hydrolase activity.

The biological function of bile salts in lipid digestion and absorption in the intestine involves high amounts of bile salt micelles in oil-in-water emulsions. The micelles promote fat absorption by facilitating transportation of a high concentration of lipids from the water layer to the mucosal cells ([@b58-pnfs-24-434]). Mixing the oil with MRS broth containing bile salts produced an emulsified layer at the oil-water interface. Addition of TCI378 metabolites was able to deplete the emulsification and micelle formation of bile salts, indicating that TCI378 culture has bile salt hydrolase activity ([Fig. 2B](#f2-pnfs-24-434){ref-type="fig"}). Therefore, TCI378 may have an ability to reduce lipid absorption in the intestinal tract.

Bile salt hydrolase activity influences cholesterol metabolism. The ability of probiotic Lactobacilli to reduce serum cholesterol levels *in vivo* has often been correlated with their bile salt hydrolase activity ([@b47-pnfs-24-434]). In general, strains with high BSH activities show high bile salt deconjugation abilities. Increases in biliary concentrations consequently decrease cholesterol removal and the viability of the bacteria ([@b39-pnfs-24-434]). *In vitro* cholesterol-lowering tests showed TCI378 reduced the cholesterol concentration to 216 μg/mL, 48% lower than the control (413 μg/mL) ([Fig. 3](#f3-pnfs-24-434){ref-type="fig"}). Combined with its bile salt hydrolase activity, TCI378 may potentially be used for reducing serum cholesterol levels in prophylactical management of hypercholesterolemia.

Many potential mechanisms have been proposed for the cholesterol-lowering activities of probiotics with BSH activity, including regulations of bile acid binding to the farnesoid X receptor, and cholesterol export through the adenosine triphosphate binding cassette G5/G8 and Niemann-Pick C1-like 1 ([@b20-pnfs-24-434]; [@b26-pnfs-24-434]). The main mechanism for the cholesterol-lowering effect of probiotics is thought to depend on the biotransformation reaction of bile salt deconjugation, which is functional in bile detoxification ([@b20-pnfs-24-434]; [@b39-pnfs-24-434]). Hydrophobic deconjugated bile salts are reabsorbed less readily in the intestine, resulting in higher excretion in feces. Without probiotic bacteria, cholesterol is precipitated due to the reduced solubility of deconjugated bile salts. Therefore, coprecipitation of cholesterol with deconjugated bile salts at lower pH values is more required for cholesterol removal rather than assimilation or uptake of cholesterol by bacterial cells ([@b54-pnfs-24-434]). Since TCI378 has shown potential to grow at a low pH and in bile salts, consumption may assist coprecipitation of cholesterol with deconjugated bile salts in gastrointestinal juice of the upper digestive tract.

*Lab. plantarum* TCI378 and its metabolites suppress adipogenesis and levels of lipogenesis-related factors
-----------------------------------------------------------------------------------------------------------

Differentiated adipocytes accumulate large amounts of oil droplets, demonstrated by control cells cultured in adipocyte maintenance medium, both with and without 1% MRS broth ([Fig. 4A](#f4-pnfs-24-434){ref-type="fig"}). However, the sizes and amounts of lipid droplets were reduced in 3T3-L1 cells treated with 1% TCI378 metabolites ([Fig. 4A](#f4-pnfs-24-434){ref-type="fig"}). Quantification of total lipid accumulation showed a 14% reduction in adipocytes treated with 1% TCI378 metabolites compared with controls ([Fig. 4B](#f4-pnfs-24-434){ref-type="fig"}). In addition, supplementation with dead TCI378 bacteria reduced lipid accumulation in 3T3-L1 by 9% compared to control cells (*P*\<0.01) (unpublished data). We further examined expression of genes related to adipogenesis and lipolysis. Treatment of 3T3-L1 cells with 1% TCI378 metabolites decreased mRNA expression for *GLUT4* and *PLIN1* by 10% and 31%, respectively ([Fig. 4C](#f4-pnfs-24-434){ref-type="fig"}).

In adipocytes, expression of *GLUT4* is induced by PPARγ during the late stages of differentiation. Once cells are transformed into mature adipocytes, GLUT4 plays a major role in metabolic regulation by glucose transportation ([@b12-pnfs-24-434]). Therefore, a reduction in GLUT4 will decrease fat formation in adipocytes. Under basal conditions, PLIN1 is found on the surface of lipid droplets and is expressed specifically in adipocytes and steroidogenic cells. Overexpression of PLIN1 in 3T3-L1 preadipocytes suppresses lipolysis and limits access of lipases to lipid droplets ([@b6-pnfs-24-434]). Conversely, suppression of PLIN1 may promote fragmentation of larger lipid droplets into smaller droplets during lipolysis, which could be advantageous for providing a larger accessible surface area for lipases ([@b37-pnfs-24-434]). To summarize, we suggest that *Lab. plantarum* TCI378 and its metabolites may inhibit lipid accumulation and reduce fat formation in adipocytes through suppression of adipogenic and lipolytic activities involving GLUT4 and PLIN1.

Many *Lab. plantarum* strains have been isolated from fermented kimchi. Probiotic characteristics of different strains are thought to be source-specific. Specifically, differing functions of *Lab. plantarum* strains isolated from kimchi have been reported, including: anti-obesity effects of Ln4 and HAC01 ([@b32-pnfs-24-434]; [@b44-pnfs-24-434]), anti-pathogenic effects of KC21, DK211/303, YML007, and AF1 ([@b1-pnfs-24-434]; [@b4-pnfs-24-434]; [@b35-pnfs-24-434]; [@b63-pnfs-24-434]), and immunoregulatory effects of CJLP55/56/133/136, PM008, CLP-0611, and HY7712 ([@b22-pnfs-24-434]; [@b23-pnfs-24-434]; [@b24-pnfs-24-434]; [@b60-pnfs-24-434]). In this study, we reported the functional specificity of *Lab. plantarum* strain TCI378. TCI378 shows probiotic BSH activity in cholesterol removal and anti-obesity; these results provide insight into the mechanisms of action of probiotic bacteria against obesity and hypercholesterolemia.

In conclusion, we used *in vitro* evaluation to show the indigenous *Lab. plantarum* strain TCI378 isolated from naturally fermented kimchi may promote gastrointestinal function, cholesterol metabolism, and anti-obesity effects. As candidate probiotics, TCI378 and its metabolites may be used as dietary supplements to improve human health.
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![*Lactobacillus plantarum* TCI378 (TCI378) is tolerant to low pH and bile acids. (A) The survival cell number of TCI378 cultured in MRS broth of pH 7.0 or pH 3.0 was calculated after taking the base 10 logarithm. (B) The survival cell number of TCI378 cultured in MRS broth only (MRS) or MRS broth supplement with 0.3% bile acids (MRS+bile acid) was calculated after taking the base 10 logarithm. The data are presented as mean±SD. CFU, colony-forming unit.](pnfs-24-434f1){#f1-pnfs-24-434}

![*Lactobacillus plantarum* TCI378 (TCI378) possessed the bile salt hydrolase activity and reduced the emulsification effect of bile salts. (A) TCI378 was streaked on MRS agar plates (MRS) or MRS agar plates containing 0.5% taurodeoxycholic acid (MRS+TDCA). Comparing to the regular TCI378 colonies (close view of left plate), TCI378 formed opaque granular white colonies on MRS+TDCA plates (close view of right plate). (B) The purified metabolite of TCI378 was added to the MRS medium containing bile salts and soy oil \[TCI378(m)\]. After mix the oil-water interface, the emulsification was observed. The emulsified layer was depleted in the mixture containing TCI378(m) after incubation at 37°C for 30 min, while the emulsification remained in the control (mock).](pnfs-24-434f2){#f2-pnfs-24-434}

![*Lactobacillus plantarum* TCI378 (TCI378) cholesterollowering activity. TCI378 was cultured in MRS broth supplemented with 0.2% oxgall bile acids and 0.1 g water soluble cholesterol. The cholesterol concentration was determined in the supernatants of control (MRSC) and TCI378 culture (TCI378). Data are presented as mean±SD. \*\*\**P* \<0.001 (n=3).](pnfs-24-434f3){#f3-pnfs-24-434}

![*Lactobacillus plantarum* TCI378 (TCI378) metabolites inhibit 3T3-L1 cell adipogenesis and lipolysis. Differentiated 3T3-L1 cells were left untreated (Mock), treated with 1% MRS (blank; MRS), or treated with 1% culture supernatant without TCI378 cells (TCI378), and cultured for 2 days. (A) Images of Oil red O-stained 3T3-L1 cells on plates. (B) Levels of oil accumulation were determined by quantifying Oil red O staining. (C) Real-time RT-PCR assays were performed for the adipogenic marker gene *GLUT4* and lipolytic maker gene *PLIN1*. Data are presented as mean±SD. \**P* \<0.05 and \*\**P* \<0.01 compared with control, and ^\#^*P* \<0.05 and ^\#\#\#^*P* \<0.001 compared with MRS (n=3).](pnfs-24-434f4){#f4-pnfs-24-434}
